Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.
about
Radionuclide techniques for the assessment of myocardial viabilityMyocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure.Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature reviewClinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.Imaging myocardial metabolic remodeling.Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viabilityImpact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization.Molecular and cellular basis of viable dysfunctional myocardium.Surgical alternatives to mechanical support.Diagnostic value of (18)F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with (99m)Tc SPECT and echocardiography.Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques.Myocardial viability assessment using nuclear imaging.Pathophysiology and diagnosis of hibernating myocardium in patients with post-ischemic heart failure: the contribution of PET.Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles.Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium.Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisationOutcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium.MR and CT assessment for ischemic cardiac disease.Radionuclide techniques for the assessment of myocardial viability and hibernation.The contribution of hibernation to heart failure.Viable myocardium: how much is enough?Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.Hibernating myocardium in heart failure.Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes.Imaging techniques in nuclear cardiology for the assessment of myocardial viability.The heart failure challenge: optimizing medical and surgical managementSurgery Insight: surgical methods to reverse left ventricular remodeling.Diagnostic and imaging considerations: role of viability.Myocardial viability assessment: poor correlation between electromechanical cardiac mapping and positron emission tomography in severe coronary artery diseaseImaging of the failing heart.Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.Surgical methods to reverse left ventricular remodeling.Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure.Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.Integrated imaging of cardiac anatomy, physiology, and viability.Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.
P2860
Q24612196-CD07EA0E-0DED-40AF-8F8B-09254BDCD0D1Q26865768-CDCEED82-7BCB-4712-AC2B-8271F1EED911Q26992237-532A53F2-87E6-48EB-BA77-FC42942113B3Q28073135-CE98A100-672A-46E0-BCDF-FFB31463E8E5Q30434499-E78D1DAB-65DB-4111-AAC9-90101794A8BFQ30439253-B4D70CC2-F95C-40A8-A683-C1B74642ACD0Q30464469-F2007C2A-9C7B-42B8-B978-1BB1C8A40FCEQ30573782-927FEDA9-9113-45E3-AD7B-5049B9CDF53FQ33759444-52958653-4304-4616-B9F8-697DB1A6F433Q33781237-E1503B20-1746-4584-85A5-C33BBF594566Q33924001-A8C65972-E2DA-40F6-88C3-E34C6367182FQ33991416-F5C9F141-0ED7-4F6C-A36A-2FD71BE3FEFEQ34260453-5CC1EF24-35B0-40BC-8AEE-413E4D6A7D25Q35031084-6604794E-A6AE-4C1B-851A-51D0380072A1Q35150699-5709539C-05D1-4C30-A360-F9681ADA10CAQ35170817-98A17CAB-0801-42EF-A2CB-AAB206A319CEQ35217711-C97800BB-2868-4B0A-A82D-F3938F83F7D9Q35369973-E03DB0F4-2EE0-4AD2-8F0A-EF6E1BC1C12AQ35583699-0140CE04-17DD-4C27-B7C8-C766E593A8CCQ35771303-A27369E7-7D50-4B1F-B153-491AED71D9A4Q35773117-0B6DA220-8A3C-4A47-99C9-26A291027B79Q35788327-07DF2E9C-DB26-4B5B-B49B-0EB7BFD61BD1Q35836570-8DD6DDD6-57FE-492D-9381-90FA3428CBE9Q35932356-A31980A1-7CDF-483B-BC55-DE4E3941A2D3Q36014884-927D8B38-3202-4BCA-82A4-BD067F177D20Q36031580-3DC357F7-5FF2-42C6-BD5C-37CACDCFCF17Q36050499-5BA41D34-6084-41CF-BE42-D1C5C07A8150Q36117344-BB0B1A94-C7A4-4B66-AAB8-3ED380006A41Q36350284-E450B39A-8444-4198-B6CC-F46D52B0E86FQ36575456-103553FA-5A0E-4B97-85F0-860D40C555A2Q36577572-ECFFA644-2751-4880-96D6-07EF8D02C7FEQ36579484-EE8BEBF6-91D2-4FCB-9D13-6FA9DD1F80F8Q36813158-B068DF8D-AA86-4BF9-98AE-59F5E3CD7439Q36902522-1F51B84D-E300-430E-913C-98A7C7BF8F57Q37057956-B5889DA3-21CC-4407-B6B4-A8E298446A29Q37067656-359BDF11-645A-4A57-B29F-1E26A434C199Q37254555-BAB1E02A-4EC7-4BFC-B45C-0FA59DB6BFF1Q37352122-DE08C54F-4730-49AD-9842-EEBEC70D0537Q37399539-5CF02F04-5E51-451B-A5E4-A9C72E7A3F06Q37656286-FA7617AF-192D-4019-AA1A-9E6BA361B463
P2860
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Quantitative relation between ...... with ischemic cardiomyopathy.
@en
Quantitative relation between ...... with ischemic cardiomyopathy.
@nl
type
label
Quantitative relation between ...... with ischemic cardiomyopathy.
@en
Quantitative relation between ...... with ischemic cardiomyopathy.
@nl
prefLabel
Quantitative relation between ...... with ischemic cardiomyopathy.
@en
Quantitative relation between ...... with ischemic cardiomyopathy.
@nl
P2093
P921
P1433
P1476
Quantitative relation between ...... with ischemic cardiomyopathy.
@en
P2093
Asgarzadie F
Brunken RC
Di Carli MF
Schelbert HR
P304
P356
10.1161/01.CIR.92.12.3436
P407
P577
1995-12-01T00:00:00Z